MCID: ATR005
MIFTS: 45

Atrophic Gastritis malady

Categories: Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Atrophic Gastritis

Aliases & Descriptions for Atrophic Gastritis:

Name: Atrophic Gastritis 12 14
Gastritis, Atrophic 42 69
Gastritis Atrophic 52
Gastric Atrophy 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8929
ICD10 33 K29.4
ICD9CM 35 535.1 535.11
MeSH 42 D005757
NCIt 47 C7405

Summaries for Atrophic Gastritis

MalaCards based summary : Atrophic Gastritis, also known as gastritis, atrophic, is related to autoimmune atrophic gastritis and gastritis, and has symptoms including dyspepsia An important gene associated with Atrophic Gastritis is CHGA (Chromogranin A), and among its related pathways/superpathways are Spinal Cord Injury and Interleukin-4 and 13 signaling. The drugs Amphotericin B and Hydroxocobalamin have been mentioned in the context of this disorder. Affiliated tissues include thyroid, testes and t cells.

Wikipedia : 71 Atrophic gastritis (also known as Type A or Type B Gastritis more specifically) is a process of chronic... more...

Related Diseases for Atrophic Gastritis

Diseases in the Atrophic Gastritis family:

Autoimmune Atrophic Gastritis

Diseases related to Atrophic Gastritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 111)
id Related Disease Score Top Affiliating Genes
1 autoimmune atrophic gastritis 12.4
2 gastritis 11.1
3 megaloblastic anemia-1, finnish type 10.8
4 gastric cancer 10.6
5 pernicious anemia 10.3
6 autoimmune pancreatitis 10.3 CHGA GAST
7 secondary syphilis 10.3 CHGA GAST
8 brain edema 10.3 CHGA GAST
9 oculomotor nerve paralysis 10.3 CXCL8 IL1B
10 common peroneal nerve lesion 10.2 CXCL8 IL1B
11 peritoneal benign neoplasm 10.2 CDX2 CHGA
12 dystonia 10.2 CDX2 CHGA
13 anal canal paget's disease 10.2 CDX2 CHGA
14 nutritional optic neuropathy 10.2 GAST GHRL
15 adenocarcinoma 10.2
16 coronary arterial fistulas 10.2 CXCL8 IL1RN
17 senile reticular retinal degeneration 10.2 CXCL8 IL1B IL1RN
18 autosomal recessive type iv ehlers-danlos syndrome 10.2 CXCL8 IL1B IL1RN
19 gastric ulcer 10.2
20 esophagitis 10.2
21 epithelioid malignant peripheral nerve sheath tumor 10.2 CHGA ODC1
22 skin conditions 10.2 CXCL8 IL1B IL1RN
23 classic type lipoma 10.2 CXCL8 IL1B IL1RN
24 synovium cancer 10.2 CXCL8 IL1B IL1RN
25 granulocytopenia 10.1 CHGA GAST
26 bare lymphocyte syndrome, type i 10.1 CXCL8 IL1B IL1RN
27 bone angioendothelial sarcoma 10.1 CXCL8 IL1B IL1RN
28 mucositis 10.1
29 hepatocellular carcinoma 10.1 IL1B IL1RN
30 gastric duplication cysts 10.1 CHGA GAST GHRL
31 vein disease 10.1 GAST S100A8
32 acinar cell cystadenocarcinoma 10.1 CHGA GAST GHRL
33 histiocytosis 10.1 CXCL8 IL1B IL1RN
34 duodenitis 10.1
35 intratubular embryonal carcinoma 10.1 CXCL8 IL1B IL1RN
36 egg allergy 10.1 IL1B IL1RN
37 pigmentation disease 10.1 CXCL8 IL1B ODC1
38 nasal cavity cancer 10.1 CXCL8 GAST IL1B IL1RN
39 acute eustachian salpingitis 10.1 CDX2 GAST S100A8
40 h. pylori infection 10.1
41 duodenal ulcer 10.1
42 mandibular cancer 10.0 CXCL8 GHRL PGC
43 gastroesophageal reflux 10.0
44 pancreatitis 10.0
45 warthin tumor 10.0 IL1B IL1RN
46 classic congenital mesoblastic nephroma 10.0 CHGA TP53
47 postpoliomyelitis syndrome 10.0 CDX2 GAST TP53
48 colorectal cancer 10.0
49 deficiency anemia 10.0
50 vitamin b12 deficiency 10.0

Comorbidity relations with Atrophic Gastritis via Phenotypic Disease Network (PDN): (show all 18)


Active Peptic Ulcer Disease Acute Cystitis
Acute Pancreatitis Anxiety Disorder
Bronchitis Chronic Myocardial Ischemia
Deficiency Anemia Duodenitis
Dysthymic Disorder Esophagitis
Heart Disease Hypertension, Essential
Intermediate Coronary Syndrome Iron Deficiency Anemia
Irritable Bowel Syndrome Ischemic Heart Disease
Paralytic Ileus Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Atrophic Gastritis:



Diseases related to Atrophic Gastritis

Symptoms & Phenotypes for Atrophic Gastritis

UMLS symptoms related to Atrophic Gastritis:


dyspepsia

Drugs & Therapeutics for Atrophic Gastritis

Drugs for Atrophic Gastritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 109)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amphotericin B Approved, Investigational Phase 4 1397-89-3 14956 5280965
2
Hydroxocobalamin Approved Phase 4 13422-51-0 11953898 5460373 44475014
3
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
4
Esomeprazole Approved, Investigational Phase 4 161796-78-7, 119141-88-7 4594 9579578
5
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757 53477783
6
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
7
Metronidazole Approved Phase 4,Phase 3 443-48-1 4173
8
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
9
Norgestimate Approved Phase 4 35189-28-7 6540478
10
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
11
Clarithromycin Approved Phase 4,Phase 3,Phase 2 81103-11-9 84029
12
Cyanocobalamin Approved, Nutraceutical Phase 4 68-19-9 44176380
13
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
14 Antacids Phase 4,Phase 3
15 Anti-Ulcer Agents Phase 4,Phase 3
16 Gastrointestinal Agents Phase 4,Phase 3
17
Proton pump inhibitors Phase 4,Phase 3
18 Hematinics Phase 4
19 Liposomal amphotericin B Phase 4
20 Micronutrients Phase 4
21 Trace Elements Phase 4
22 Vitamin B 12 Phase 4
23 Vitamin B Complex Phase 4
24 Vitamins Phase 4,Phase 3
25 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
26 Anti-Infective Agents Phase 4,Phase 3,Phase 2
27 Antiparasitic Agents Phase 4,Phase 3,Phase 2
28 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
29
Bismuth Phase 4 7440-69-9 16682734 105143
30 Contraceptive Agents Phase 4
31 Contraceptives, Oral Phase 4
32 Contraceptives, Oral, Combined Phase 4
33 Estradiol 17 beta-cypionate Phase 4
34 Estradiol 3-benzoate Phase 4
35 Estradiol valerate Phase 4 979-32-8
36 Fluoroquinolones Phase 4
37 Norgestimate, ethinyl estradiol drug combination Phase 4
38 Nucleic Acid Synthesis Inhibitors Phase 4
39 Polyestradiol phosphate Phase 4
40 Topoisomerase Inhibitors Phase 4
41 Geranylgeranylacetone Phase 4
42
Pectin Phase 4 9000-69-5 441476
43
Cobalamin Nutraceutical Phase 4 13408-78-1 6438156
44 Folate Nutraceutical Phase 4
45
Methylcobalamin Experimental, Nutraceutical Phase 4 13422-55-4
46 Vitamin B12 Nutraceutical Phase 4
47 Vitamin B9 Nutraceutical Phase 4
48
Guaifenesin Approved, Vet_approved Phase 3 93-14-1 3516
49
Omeprazole Approved, Investigational, Vet_approved Phase 3,Phase 2 73590-58-6 4594
50
Selenium Approved, Vet_approved Phase 3 7782-49-2

Interventional clinical trials:

(show top 50) (show all 54)
id Name Status NCT ID Phase
1 To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) Completed NCT01474044 Phase 4
2 Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy Completed NCT01792700 Phase 4
3 A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. Completed NCT01817556 Phase 4
4 Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients Completed NCT01119768 Phase 4
5 Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer Completed NCT01190657 Phase 4
6 Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality Recruiting NCT02047994 Phase 4
7 Difference of Gastric Microbiota in the Process of Correa's Model. Recruiting NCT02833363 Phase 4
8 Intragastric pH and Bismuth Effect for H. Pylori Eradication Not yet recruiting NCT02894892 Phase 4
9 The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study Not yet recruiting NCT02933229 Phase 4
10 A Study to Evaluate the Efficacy and Safety of DA-5204 Unknown status NCT02282670 Phase 3
11 A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 Unknown status NCT01813812 Phase 3
12 A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of Stomach Completed NCT01132534 Phase 3
13 Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia Completed NCT00719420 Phase 3
14 A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province Completed NCT00339768 Phase 3
15 Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis Completed NCT00996788 Phase 3
16 L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde Completed NCT02524262 Phase 2
17 Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer Completed NCT01002443 Phase 2
18 Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Recruiting NCT02782949 Phase 2
19 Chemoprevention of Gastric Carcinogenesis Recruiting NCT02794428 Phase 2
20 YF476 and Type I Gastric Carcinoids Active, not recruiting NCT01339169 Phase 2
21 YF476 and Type I Gastric Carcinoids (Norway) Terminated NCT01444014 Phase 2
22 Gastropanel for Gastric Atrophy and Cancer Risk Assessment Unknown status NCT02114411
23 Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy Unknown status NCT02126722
24 Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus Unknown status NCT00155805
25 Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer Unknown status NCT01813994
26 Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway Unknown status NCT00498134
27 Screening for Gastric Cancer in High-risk Population Unknown status NCT00815113
28 Grading Atrophic Gastritis by Confocal Laser Endomicroscopy Probe (p-CLE) Completed NCT02351154
29 Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy Completed NCT02724280
30 New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy Completed NCT02597517
31 Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years Completed NCT01824953
32 OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Completed NCT02562976
33 Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis Completed NCT00920712
34 Gastric Microbiota and Helicobacter Pylori Test Findings Completed NCT02542579
35 Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) Completed NCT00212225
36 New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy Completed NCT01896310
37 Effect of Chicken Egg Antibody (IgY) on Patients With Chronic Gastritis Completed NCT02721355
38 Helicobacter Pylori and Proton Pump Inhibitor Completed NCT02449941
39 Levothyroxine (L-T4) Absorption After Bariatric Surgery Completed NCT01189344
40 Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh? Completed NCT00284700
41 Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients Recruiting NCT02691637
42 Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea Recruiting NCT02184910
43 Gastric Cancer Screening Quality Improvement System Establishment Recruiting NCT02457624
44 HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome Recruiting NCT01931293
45 Optimal Site for Rapid Urease Test in the Stomach Recruiting NCT02945137
46 Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy Recruiting NCT02284802
47 Oxidative Stress in Intestinal Metaplasia and Metabolic Syndrome Recruiting NCT02695186
48 Volatile Markers in Digestive Cancer Recruiting NCT02332213
49 Lifestyle Intervention for Prevention of Gastric Neoplasm Recruiting NCT02679495
50 Real-time Observation of Microcirculatory Hemodynamics in Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy Recruiting NCT02595151

Search NIH Clinical Center for Atrophic Gastritis

Cochrane evidence based reviews: gastritis, atrophic

Genetic Tests for Atrophic Gastritis

Anatomical Context for Atrophic Gastritis

MalaCards organs/tissues related to Atrophic Gastritis:

39
Thyroid, Testes, T Cells, Colon, Endothelial, Skin, B Cells

Publications for Atrophic Gastritis

Articles related to Atrophic Gastritis:

(show top 50) (show all 595)
id Title Authors Year
1
Slow-release L-cysteine capsule prevents gastric mucosa exposure to carcinogenic acetaldehyde: results of a randomised single-blinded, cross-over study of Helicobacter-associated atrophic gastritis. ( 27806647 )
2017
2
NMR-based metabonomics and correlation analysis reveal potential biomarkers associated with chronic atrophic gastritis. ( 27697573 )
2017
3
Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis. ( 28049442 )
2017
4
The challenging diagnosis of autoimmune atrophic gastritis. ( 28040990 )
2017
5
The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis. ( 27149493 )
2016
6
Is It Rationale to Apply Strict Colonoscopic Surveillance in Patients with Helicobacter pylori Associated Chronic Atrophic Gastritis? ( 27784841 )
2016
7
Is Gastric Xanthelasma an Alarming Endoscopic Marker for Advanced Atrophic Gastritis and Intestinal Metaplasia? ( 27250981 )
2016
8
(18)F-FDG uptake in the stomach on screening PET/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis. ( 27756255 )
2016
9
SNP-SNP interactions of three new pri-miRNAs with the target gene PGC and multidimensional analysis of H. pylori in the gastric cancer/atrophic gastritis risk in a Chinese population. ( 26988755 )
2016
10
Clinical and Endoscopic Features of Undifferentiated Gastric Cancer in Patients with Severe Atrophic Gastritis. ( 27086796 )
2016
11
Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: a nested case-control study. ( 28032715 )
2016
12
An Unusual Presentation of Pseudothrombotic Microangiopathy in a Patient with Autoimmune Atrophic Gastritis. ( 27018160 )
2016
13
Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series. ( 26965518 )
2016
14
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study. ( 27592118 )
2016
15
Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference. ( 26513345 )
2016
16
Helicobacter pylori Infection with Atrophic Gastritis Is an Independent Risk Factor for Advanced Colonic Neoplasm. ( 27458180 )
2016
17
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis. ( 27704617 )
2016
18
Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome. ( 27851820 )
2016
19
A Panel of Serum Biomarkers (GastroPanelAr) in Non-invasive Diagnosis of Atrophic Gastritis. Systematic Review and Meta-analysis. ( 27798873 )
2016
20
An Observational Study on Aberrant Methylation of Runx3 With the Prognosis in Chronic Atrophic Gastritis Patients. ( 27196446 )
2016
21
Association of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risks. ( 26760766 )
2016
22
Successful Eradication Therapy for Helicobacter pylori-positive Atrophic Gastritis at the Sixth Attempt: A Case Report. ( 27988924 )
2016
23
Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice. ( 26839577 )
2016
24
Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis. ( 27050149 )
2016
25
Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study. ( 26958813 )
2016
26
Cytokine-producing function of human blood cells in chronic atrophic gastritis and gastric adenomas and adenocarcinomas. ( 27193885 )
2016
27
Role of the IL-11/STAT3 signaling pathway in human chronic atrophic gastritis and gastric cancer. ( 27173233 )
2016
28
Acupuncture Decreases NF-I_B p65, miR-155, and miR-21 and Increases miR-146a Expression in Chronic Atrophic Gastritis Rats. ( 27293468 )
2016
29
Autoimmune metaplastic atrophic gastritis in chinese: a study of 320 patients at a large tertiary medical center. ( 27652682 )
2016
30
Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanelAr) in St. Petersburg. ( 27466521 )
2016
31
Impaired skeletal health in patients with chronic atrophic gastritis. ( 26854332 )
2016
32
Exploratory Factor Analysis for Validating Traditional Chinese Syndrome Patterns of Chronic Atrophic Gastritis. ( 28077948 )
2016
33
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution. ( 26928404 )
2016
34
Cost of detecting gastric neoplasia by surveillance endoscopy in atrophic gastritis in Italy: A low risk country. ( 28034664 )
2016
35
Pernicious Anemia, Atrophic Gastritis, and the Risk of Cancer. ( 26192144 )
2015
36
Localised Skin Hyperpigmentation as a Presenting Symptom of Vitamin B12 Deficiency Complicating Chronic Atrophic Gastritis. ( 26357561 )
2015
37
Oesophageal adenocarcinoma and atrophic gastritis. ( 26114911 )
2015
38
Positive relationship between p42.3 gene and inflammation in chronic non-atrophic gastritis. ( 26316259 )
2015
39
Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis. ( 26321479 )
2015
40
Effect of ERCC8 tagSNPs and their association with H. pylori infection, smoking, and alcohol consumption on gastric cancer and atrophic gastritis risk. ( 26130415 )
2015
41
A polysaccharide from cultured mycelium of Hericium erinaceus and its anti-chronic atrophic gastritis activity. ( 26314904 )
2015
42
Autoimmune Metaplastic Atrophic Gastritis: Recognizing Precursor Lesions for Appropriate Patient Evaluation. ( 26291507 )
2015
43
Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation. ( 26486508 )
2015
44
Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. ( 25645880 )
2015
45
Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis. ( 26556485 )
2015
46
Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar. ( 25605987 )
2015
47
Determination of whether screening tests for chronic atrophic gastritis really has a positive predictive value. ( 26035809 )
2015
48
Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis. ( 26223472 )
2015
49
Response to: misleading results in the diagnosis of atrophic gastritis. ( 25426983 )
2015
50
Time Trends in Helicobacter pylori Infection and Atrophic Gastritis Over 40A Years in Japan. ( 25581708 )
2015

Variations for Atrophic Gastritis

Expression for Atrophic Gastritis

Search GEO for disease gene expression data for Atrophic Gastritis.

Pathways for Atrophic Gastritis

GO Terms for Atrophic Gastritis

Cellular components related to Atrophic Gastritis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.76 CHGA CXCL8 GAST GHRL IL1B IL1RN
2 extracellular region GO:0005576 9.4 ADH7 CHGA CXCL8 GAST GHRL IL1B
3 multivesicular body lumen GO:0097486 9.13 PGA3 PGA4 PGA5

Biological processes related to Atrophic Gastritis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.67 CXCL8 IL1B IL1RN S100A8
2 digestion GO:0007586 9.46 PGA3 PGA4 PGA5 PGC
3 neutrophil chemotaxis GO:0030593 9.43 CXCL8 IL1B S100A8
4 positive regulation of protein export from nucleus GO:0046827 9.32 IL1B TP53
5 protein catabolic process GO:0030163 9.26 PGA3 PGA4 PGA5 PGC
6 autophagy GO:0006914 9.1 PGA3 PGA4 PGA5 PGC S100A8 TP53

Molecular functions related to Atrophic Gastritis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 interleukin-1 receptor binding GO:0005149 8.96 IL1B IL1RN
2 aspartic-type endopeptidase activity GO:0004190 8.92 PGA3 PGA4 PGA5 PGC

Sources for Atrophic Gastritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....